Powered by

Kura Oncology to Participate in Two Upcoming Investor Conferences

Aug 29, 2019 - GlobeNewswire

SAN DIEGO, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of cancer, today announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in two upcoming investor conferences:

A panel discussion entitled "Focusing the Laser on Precision Oncology" at Citi's 14th Annual Biotech Conference in Boston at 9:30 a.m. ET...